Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Sunshine Biopharma (SBFM) over the last 14 years, with Q3 2025 value amounting to $441489.0.

  • Sunshine Biopharma's Prepaid Assets fell 3999.85% to $441489.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $441489.0, marking a year-over-year decrease of 3999.85%. This contributed to the annual value of $1.1 million for FY2024, which is 26488.4% up from last year.
  • As of Q3 2025, Sunshine Biopharma's Prepaid Assets stood at $441489.0, which was down 3999.85% from $939436.0 recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Prepaid Assets ranged from a high of $1.8 million in Q2 2024 and a low of $10993.0 during Q1 2021
  • Moreover, its 5-year median value for Prepaid Assets was $152262.0 (2023), whereas its average is $419399.4.
  • Its Prepaid Assets has fluctuated over the past 5 years, first soared by 185919.69% in 2024, then tumbled by 4711.81% in 2025.
  • Sunshine Biopharma's Prepaid Assets (Quarter) stood at $29625.0 in 2021, then surged by 857.97% to $283799.0 in 2022, then increased by 9.44% to $310591.0 in 2023, then surged by 264.88% to $1.1 million in 2024, then plummeted by 61.04% to $441489.0 in 2025.
  • Its Prepaid Assets was $441489.0 in Q3 2025, compared to $939436.0 in Q2 2025 and $983536.0 in Q1 2025.